Google AI health coach to use Abbott glucose data
Abbott and Google are integrating continuous glucose monitoring data from Lingo into the Google Health app and Gemini-powered Health Coach.
Stock photo for illustration only, not from the actual event
- Abbott and Google signed a multiyear agreement to integrate Lingo glucose data into Google Health.
- Google Health Coach, powered by Gemini, will offer tailored wellness recommendations.
- Lingo is an over-the-counter glucose monitoring system for adults aged 18 and older not using insulin.
- The companies are also planning a large real-world study focused on metabolic health.
Abbott and Google are linking continuous glucose monitoring data with Google’s AI-powered health coaching tools, giving the Gemini-powered service access to a vital new source of personal health information. Under a multiyear agreement, data from Abbott’s Lingo continuous glucose monitor will be integrated directly into the Google Health app.
Users will soon be able to view their glucose trends alongside information related to physical activity, sleep patterns, and other wellness metrics in one unified dashboard. Google Health Coach, built with Gemini, will utilize Lingo data alongside other integrated health information to provide comprehensive recommendations covering nutrition, activity, sleep, and recovery, though access to the AI coach requires a Google Health Premium subscription.
Google maintains that Health Coach is not intended for medical purposes and warns that AI responses can sometimes be inaccurate or incomplete. The tech giant advises users to carefully verify responses and consult qualified healthcare professionals when appropriate.
Stock photo for illustration only, not from the actual event
Integrating continuous glucose data into consumer AI coaching represents a major shift toward proactive health management, allowing individuals to immediately see how daily nutrition and exercise impact their glucose levels. However, balancing automated wellness suggestions with clinical safety remains a critical regulatory hurdle for tech companies entering the digital health space.
Lingo is designed as an over-the-counter continuous glucose monitoring system targeted at adults aged 18 and older who do not use insulin. The wearable tracks glucose levels continuously throughout its 14-day wear period by measuring glucose in interstitial fluid via a sensor inserted on the back of the upper arm, transmitting readings to the Lingo app through Bluetooth Low Energy.
While Lingo shares foundational sensor technology with Abbott’s FreeStyle Libre platform, their intended uses differ significantly. FreeStyle Libre 2 is cleared specifically for diabetes management, whereas Lingo serves to help adults understand how daily activities and diet relate to glucose fluctuations. To further refine these capabilities, Abbott and Google are planning a large-scale real-world study combining continuous glucose readings with wearable, laboratory, and survey data.
Source: AI News
Found something wrong in this article? Report an issue with this article
Comments
Leave a Comment